Biogen Inc (BIIB)
194.44
+3.99
(+2.10%)
USD |
NASDAQ |
Apr 19, 16:00
194.44
0.00 (0.00%)
After-Hours: 20:00
Biogen Total Return Level: 190.45 for April 18, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 18, 2024 | 190.45 |
April 17, 2024 | 192.16 |
April 16, 2024 | 195.15 |
April 15, 2024 | 196.80 |
April 12, 2024 | 198.18 |
April 11, 2024 | 203.68 |
April 10, 2024 | 201.55 |
April 09, 2024 | 206.52 |
April 08, 2024 | 204.95 |
April 05, 2024 | 203.87 |
April 04, 2024 | 205.30 |
April 03, 2024 | 206.38 |
April 02, 2024 | 207.64 |
April 01, 2024 | 214.83 |
March 28, 2024 | 215.63 |
March 27, 2024 | 216.34 |
March 26, 2024 | 212.02 |
March 25, 2024 | 216.69 |
March 22, 2024 | 218.10 |
March 21, 2024 | 220.75 |
March 20, 2024 | 218.15 |
March 19, 2024 | 218.63 |
March 18, 2024 | 219.40 |
March 15, 2024 | 219.31 |
March 14, 2024 | 219.62 |
Date | Value |
---|---|
March 13, 2024 | 226.56 |
March 12, 2024 | 227.36 |
March 11, 2024 | 230.07 |
March 08, 2024 | 223.24 |
March 07, 2024 | 219.36 |
March 06, 2024 | 217.56 |
March 05, 2024 | 217.23 |
March 04, 2024 | 221.02 |
March 01, 2024 | 220.95 |
February 29, 2024 | 216.99 |
February 28, 2024 | 221.74 |
February 27, 2024 | 223.94 |
February 26, 2024 | 223.71 |
February 23, 2024 | 223.32 |
February 22, 2024 | 222.48 |
February 21, 2024 | 221.11 |
February 20, 2024 | 219.21 |
February 16, 2024 | 219.08 |
February 15, 2024 | 223.35 |
February 14, 2024 | 220.74 |
February 13, 2024 | 226.65 |
February 12, 2024 | 244.74 |
February 09, 2024 | 240.98 |
February 08, 2024 | 240.30 |
February 07, 2024 | 240.54 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
187.54
Minimum
May 09 2022
414.71
Maximum
Jun 10 2021
263.66
Average
267.27
Median
Total Return Level Benchmarks
Eli Lilly and Co | 2147.17 |
Bristol-Myers Squibb Co | 193.26 |
AbbVie Inc | 263.12 |
Amgen Inc | 365.28 |
Regeneron Pharmaceuticals Inc | 893.50 |